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ABSTRACT
International Journal of Exercise Science 11(3): 657-668, 2018. Children with cancer report motor
problems several years post treatment. Physical performance limitations can restrict the survivor's ability to
participate fully in daily activities necessary for self-care, family life, and/or work. Motor performance in
childhood cancer could be an important measure in symptom research. This review addresses motor performance
limitations caused by cancer treatment in childhood cancer survivors. Several studies found performance deficits
in strength and flexibility. Conflicting research in balance, coordination, and reaction time needs further
consideration. The findings may indicate muscle atrophy as a cause of performance limitations rather than
neurological issues caused by treatment. The evidence that suggest motor performance is affected by cancer and
its treatment is still not fully understood. Larger cohorts of pediatric cancer patients during and after treatment
phase are warranted to examine exercise as a preventative measure for deficiencies in motor performance.

KEY WORDS: Motor control, performance limitations, impairment, acute lymphoblastic
leukemia
INTRODUCTION
Childhood cancer is the leading cause of disease-related death among 1 to 19 year olds in the
United States (28). Survival rates vary across cancer type. Up to 80% of children and
adolescents who are diagnosed with cancer live >5 years after cancer diagnosis (15). Cancer
treatment kills cells that cultivate quickly. Healthy cells in a child are growing quickly as they
are developing and growing much quicker than healthy adult cells. Treatment can damage
healthy cells and keep them from developing normally. The treatment responsible for survival
can produce adverse long-term health-related outcomes that can occur months or years after
completion of cancer treatment. Long term health-related outcomes contribute to 60-90% of
chronic health conditions developed from childhood cancer and its treatment (2, 7, 17).
Long-term impairments in intellectual, emotional, and physical functioning can be caused by
malignancies and cancer treatments. Motor performance is the body’s physiological response
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to an internal or external stimulus that causes movement. Children with cancer report motor
problems several years post treatment when compared to their healthy counterparts (4, 11).
Physical function and performance is becoming more relevant in symptom research (25). A
number of chemotherapeutic agents used in the treatment of childhood malignancies have
side effects that can lead to decreased motor performance. Children that are treated with
radiation and chemotherapy are more likely to experience limitations in exercise performance
than those treated with surgery alone. This is due to tissue damaging effects of the treatment
(21). Performance limitations can restrict the survivor's ability to participate fully in daily
activities necessary for self-care, family life, or work. Ness and Gurney (20) found the risk for
performance limitations are greater in patients who had brain cancer, bone cancer,
neuroblastoma, soft-tissue sarcoma, or Hodgkin lymphoma. These cancer types could be
initiating neurological and/or musculoskeletal limitations in childhood cancer patients (5).
Reduced levels of physical activity, physical functioning, and health related quality of life in
pediatric cancer patients can cause long term impairments in physical functioning and daily
activity. (3, 16, 23, 27, 33). Survivors of childhood cancer have physiological deficits inhibiting
functional capacity that cannot be reconditioned by participation in regular physical activity
(13).
Previous literature has suggested that motor function disability in childhood cancer patients or
survivors is thought to be initiated by insufficient muscle activity leading to muscle weakness
(32). This can lead to reduced physical functioning. Hoffman et al. (13) indicates that poor
physical functioning in cancer patients may result from physiological deficits from treatment
rather than sedentary behaviors and bed rest. In a separate study, physical performance of
acute lymphoblastic leukemia (ALL) patients treated without stem cell transplant (SCT) did
not differ from that of the healthy control population (26). This suggests treatment type may
play a role in physiological deficits. Hypoplasia to a muscle group could be caused by both
treatment and bed rest and can negatively affect the function of the musculoskeletal system.
The resultant dysfunction can subsequently lead to disuse and deconditioning that can impair
performance (30). This may lead to additional bed rest and therefore further weakness and
further deconditioning.
The purpose of this review is to provide an evaluation of the effects of cancer treatments on
physical motor performance in children diagnosed with childhood cancer. Cancer treatment
can include surgical methods, chemotherapy, radiotherapy, SCT, and/or targeted therapy.
Based upon current research, it is hypothesized that a decline in gross motor performance in
childhood cancer patients is to be expected when compared to healthy counterparts.
METHODS
The following databases; CENTRAL, MEDLINE, PubMED, SportDISCUS, Cochrane
Databases, PEDro (Physiotherapy Evidence Database), EMBASE, were used. Articles were
identified by using combinations of the following key words: exercise, physical activity,
physical therapy resistance, strength, cardiorespiratory, cardiovascular, training, cancer,
leukemia, acute lymphoblastic leukemia, stem cell treatment, pediatric, childhood, children,
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adolescent, young adult, teenage. The year of publication was pre-selected in the search filter
2008-2015.
Studies were included in this review if they met several criteria. Randomized control trials,
randomized clinical trials, systematic reviews, meta-analysis and cohort studies were used
based on evidence strength (Level of evidence Ia-IIb; Table 1)
Table 1: Classification and judgment of the strength of evidence
Level of Type of study/publication
Strength of evidence
evidence
Ia
Meta-analysis of randomized, controlled
Convincingª/Probableᵇ/Possibleᶜ
intervention studies
Ib
Randomized controlled intervention
Probableᵇ/Possibleᶜ
studies
Ic
Non-randomized/non controlled
Probableᵇ/Possibleᶜ
intervention studies (if well designed
otherwise level IV)
IIa
Meta-analysis of cohort studies
Convincingª/Probableᵇ/Possibleᶜ
IIb
Cohort studies
Probableᵇ/Possibleᶜ/insufficientᵈ
IIIa
Meta-analysis of case-control studies
Probableᵇ/Possibleᶜ
IIIb
Case-control studies
Possibleᶜ/insufficientᵈ
IV
Non-analytical studies (case reports,
Possibleᶜ/insufficientᵈ
opinions of experts, did not determine
strength of evidence.
ª Is assigned if there are a considerable amount of studies including prospective
observational studies and, wherever possible, randomized control studies of sufficient size,
duration and quality with consistent results.
ᵇ Is assigned if epidemiological studies show fairly consistent relations between factor and
disease, but there are noticeable weakness regarding evidence or there is evidence of an
opposite relation, which does not show judgment.
ᶜ Is assigned if the results on an association between exposure and target disease are
mainly based upon case-control studies and cross sectional studies. There are only
insufficiently performed controlled intervention studies, observational studies, or noncontrolled clinical trials.
ᵈ Is assigned if there are a few study results that indicate an association between a factor
and a disease, but they are not sufficient to establish the relation. There is only limited or
no evidence from randomized intervention studies
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To be included, studies must have limited participation to subjects aged 18 and under at time
of original diagnosis and must have been undergoing or completed cancer treatment.
Participants must have started the exercise intervention within 5 years from original diagnosis.
Any test that included a form of physical activity that measured the outcome measures listed
below. Location could have been at an exercise facility, or under specialists care
(hospital/physical therapy center) or combination.
Primary outcome measures included: gross motor skills; coordination, reaction time, balance,
strength, flexibility. Secondary outcomes are to include: physical activity level, health related
quality of life. Testing was performed within 5 years of diagnosis and patients must have been
currently undergoing prescriptive treatment (minimum of one treatment) or were within 3
years post cancer treatment.
After the initial search strategy, identification of studies meeting the inclusion criteria was
employed. Eligible studies that met inclusion criteria within the title and abstract were
obtained in full. Details for exclusion were clearly stated for the eligible studies.
Data extraction was performed using standardized forms with information regarding: the
study design, participant baseline characteristics, setting, sample size, number of participants
in each study, type of intervention(s), duration of intervention, randomizations and blinding
procedure, type of control group, type of treatment and stage of treatment, duration of patient
follow-up, outcome measures extracted will include: gross motor skills; coordination, reaction
time, balance, strength, flexibility, physical activity level, health related quality of life
RESULTS
Keyword searches in CENTRAL, MEDLINE, PubMED, SportDISCUS, Cochrane Databases,
and EMBASE yielded 942 studies. Duplicate studies and title search reduced initial total to 192
studies. Abstract review provided 26 studies and full article review led to 6 intervention
studies between 2008 and 2014 that met the inclusion criteria (Figure 1, details of included
studies are found in table 2).
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Initial search strategy using terms:
• Childhood, children, pediatric.
• Cancer, leukemia, tumor.
• Physical activity, motor control, motor
performance.
N=942
Duplicate studies:
N = 124
Unique citations:
N = 818

Non cancer literature excluded based
upon review of title:
N = 402

Cancer literature:
N= 416

Excluded studies based upon title
review
N= 224

Childhood cancer and motor performance
literature:
N =192

Excluded studies based upon abstract
review
N= 166

Refined literature collected
N= 26

Excluded studies based upon full
article review
N= 20

Total included studies
N= 6
Figure 1. Search and refinement strategy for included studies.

Nineteen studies are excluded from the review for the following purposes: did not include
interested age category, did not use exercise as an intervention, were qualitative in nature,
used questionnaires for data collection, did not measure motor performance, and/or were
review studies.
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Table 2: Included studies and their characteristics

2013

Gotte

2014

Hovi

2010

Piscione

2014

Taskinen

2014

Strength

De Luca

Reaction time

2013

Aim
Flexibility

Beulertz

Type of
Article

Coordination

Title

Balance

First
author

Specific deficit analyses
in motor performance
and quality of life of
pediatric cancer
patients-a crosssectional pilot study
Gross and
fine motor skills
in children treated for
acute lymphoblastic
leukemia,
Motor performance
in children and
adolescents
with cancer at the end
of acute treatment
phase
Suboptimal long term
physical performance
in children and young
adults after pediatric
allo-SCT
Physical functioning in
pediatric survivors of
childhood posterior
fossa brain tumors

Cross
sectional

Evaluate motor
performance and healthrelated quality of life in a
mixed pediatric cancer
population.

ü

ü

ü

ü

ü x
x

Controlled
trial

Identify deficits in motor
performance in young
children diagnosed with
ALL

ü

ü
x

Cross
sectional

Analyze motor
performance at the end of
the acute treatment phase
and reveals potential risk
factors for motor deficits

ü

ü

Controlled
trial

Assess the physical fitness
of transplanted children in
a comprehensive manner,
using a defined set of tests

Controlled
trial

Physical performance
of no transplanted
childhood ALL
survivors is
comparable to healthy
controls

Observation

Describe physical
functioning of pediatric
survivors using a measure
of physical performance
validated for children
Evaluate the fitness of
multiple muscle groups in
a cohort of children and
adolescents after modern
conventional ALL therapy
without SCT.

ü

ü

ü

ü

ü

ü

ü

ü

ü

ü

ü

A total of 279 childhood cancer patients took part in the included studies. Two studies
investigated the effect of treatment on motor performance in children with ALL (6, 26), 2
studies examined the effect of treatment on motor performance in children with various cancer
types (4, 14), one study looked at posterior brain fossa tumors (24) and one study examined
stem cell transplants and how that could affect motor performance in children (14). The ages of
the children and adolescents ranged from 2.5-18.
Testing procedures and outcome measures differed between the studies. Of the 6 studies 4
measured coordination of the child (4, 6, 14, 24), 2 studies examined reaction time (4, 14), 4
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considered balance (4, 6, 8, 24) all 6 measured strength of the patient (4, 6, 8, 14, 24, 26), and 4
studies examined flexibility (4, 8, 14, 26). Two studies used the same procedure and test
battery (8, 26), the rest used 5 different measures (4, 6, 14, 24).
Table 3. Significant difference of outcome measures in included studies.
Cancer

Balance

Coordination

Flexibility

Reaction time

Strength

Beulertz

All types

NS

0.01*

0.01*

NS

0.01*

De Luca

ALL

NS

NS

-

-

NS

Gotte

All types

0.01*

NS

0.01*

0.012**

0.01*

Hovi

SCT

-

-

0.01*

-

0.01*

Piscione

Brain

0.01*

0.01*

-

-

0.05**

Taskinen

ALL

-

-

0.01*

-

0.01*

NS, non-significant outcome; * p=0.01,

99th

percentile; ** p=0.05, 95% percentile; - was not a measures variable

Twenty-meter sprint, push up, sit ups, and standing broad jump were used by Beulertz et al.
(4) to measure strength, the child’s ability to react to a stimulus to measure reaction time,
sideways jumps and balancing backwards to measure balance and coordination, and forward
bend to measure flexibility in 26 pediatric cancer patients, post treatment (age: 4-17). The
authors found no significant difference in balance (p=1.000) and reaction time (p=0.096) when
compared to reference data. Coordination (p=0.001), strength (p=0.001), flexibility (p=0.033)
and the total global score (p=0.000) of the test battery were highly significant compared to the
control population. There was no significant difference determined between the study group
and healthy children of the same age in terms of health related quality of life (p=.380).
De Luca et al. (6) used the Movement Assessment Battery for Children-2 (MABC-2) to assess
gross motor (coordination) and balance and the Bruininks-Oseretsky Test of Motor Proficiency
2nd edition short form (BOT-2 SF) to assess coordination, strength, and agility in 37 (age: 2.5-4)
child survivors of ALL. 27% of children showed motor impairment in MABC-2 (balance and
coordination) and 16% of children showed motor impairment in BOT-2 SF (coordination,
strength, and agility).
The MOON test battery was used by Gotte et al (8) to measure motor performance of 47
pediatric cancer patients (age: 6-18). Static stand was used to test balance, an optical stimulus
was used to measure reaction time, throwing at a target, measured coordination, stand and
reach was used to measure flexibility, and hand-held dynamometry was used to measure
strength. Balance (p=0.003), flexibility (p=<0.001), strength (p=<0.001), and reaction time
(p=0.012) showed significant differences between cancer patients and reference values and
coordination showed no significance (p=0.172). 55% of study participants fell below the
reference value for balance, 57% for reaction time, 89% for flexibility, and 91% for strength.
Hovi et al. (14) used the leg lift test and repeated squatting test to measure strength. The sit
and reach test and back extension test to measure flexibility in 94 patients who had SCT. The
authors looked at early testing (1-2 years after treatment) and late testing (>4 years after
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treatment). The results from early testing indicated that strength and flexibility was
significantly lower on all levels (p=0.001) when compared to healthy controls. Patients who
had exercised more regularly and were members of a sports club (n=15) performed better in
the sit and reach (p=0.002), and back extension (p=0.007).
Measurements were obtained by Piscone et al. (24) using the BOT-2 assessment for balance (9
items), coordination (7items) and strength (5items) in 30 children (age 4-18) who had
previously been diagnosed with posterior fossa brain tumors, >1 year post treatment.
Significant differences were found between survivors and normative data in balance (p=0.001)
and coordination (p=0.001). Strength was found to be significant in the 95th percentile
(p=0.026) demonstrating significantly lower gross motor functioning when compared with
normative data.
Taskinen et al. (26) used the leg lift test, and repeated squatting test to measure strength and
the sit and reach test and back extension test to measure flexibility in 45 ALL patients within 3
years of chemotherapy treatment. Strength testing was found to be insignificant in leg lift and
repeated squatting test. Flexibility differences were significant in both the sit and reach
(p=0.001) and back extension (p=0.001). BMI and physical activity level were significant factors
with respect to strength tests (p=0.001) when compared to healthy controls. Patients with a
BMI below median and who exercised > 3 times per week had better muscle performance.
DISCUSSION
This review evaluates motor performance limitations caused by cancer treatment in childhood
cancer survivors. Findings reveal significant impairments in motor performance among
children who have undergone treatment (<5 years). This is seen in strength (5 of 6 studies),
and flexibility (4 of 4 studies). Cancer and its treatment may have an impact on these particular
motor skills. Children who are ambulatory during and post treatment appear to be functioning
normally but are severely deconditioned compared to healthy counterparts. Balance (2 of 4),
coordination (2 of 4), and reaction time (1 of 2) show significant impairment when compared
to norms in 50% of the studies included. The trend shows inconclusive data and more research
is necessary to make an affirmative conclusion.
Taskinsen et al. (26) and De Luca et al (6) examined patients with ALL. No significant
differences were found in balance (6), and coordination (6). With regards to strength,
Taskinsen et al. (6) found strength to be significantly affected in ALL patients whereas De Luca
et al. (6) did not find any significance. Flexibility was significantly affected in ALL patients
(26). Time-off-treatment did not affect the prevalence of motor impairments on any measure
(6). The study that examined SCT as a form of treatment for ALL found that normal motor
functioning was impaired as SCT patients’ strength and flexibility were affected (8).
Studies that did not exclude a specific cancer type (1, 4) found significant findings in pediatric
cancer populations. Strength and flexibility were affected in both studies. Beulertz et al. (4)
found coordination to be affected by childhood cancer yet Gotte et al. (8) did not find
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significant differences. Reaction time and balance were significantly different in one study (14)
yet Beulertz et al. (4) found that reaction time and balance were not affected by childhood
cancer and its treatment. Only one study in the review examines brain tumor patients (24).
Impairments in strength, balance and coordination were observed. This was expected due to
central nervous system functioning and neurological control affected by treatment to the brain.
Based upon findings, strength and flexibility are motor skills most affected by cancer and its
treatment. This could be indicative of the degenerative effects of treatment and bedrest leading
to atrophy and stiffness. Hoffman et al., (13) gave evidence that poor physical functioning in
cancer patients may result from physiological impairments caused by treatment rather than
sedentary behaviors. The muscle deficits could be neurological deficiencies caused by
pharmaceutical agents. Wright et al., (32) argues that motor function disability in patients or
survivors of childhood cancer is caused by insufficient muscle activity. Sedentary behavior
leads to muscle weakness caused by inactivity and bed rest. Peripheral muscle strength and
ankle flexibility are reduced due to bed rest and physical inactivity in children treated for
cancer with chemotherapy (12) and this agrees with current findings. Muscle atrophy and
altered muscle function are aggravated by sedentary habits causing catabolic effects that
sedentary behavior and prolonged bed rest can induce on skeletal muscle tissue (18). Muscle
atrophy and early fatigue during low-to-moderate physical tasks soon become selfperpetuating conditions. Moyer-Mileur, Ransdell, and Bruggers (19) recognized that children
who are not active during treatment phase are more likely to experience side effects and a
decreased overall quality of life. Muscle atrophy is a common problem in children with cancer
which could be due to the catabolic effects of several chemotherapeutic agents; vincristine
and/or corticosteroids (29, 31). This, along with extended physical inactivity could be
contributing to reduced muscle function as seen in strength and flexibility.
Survivors of childhood cancers have an increased risk of secondary cancers, cardiovascular
disease, diabetes, and other secondary diseases. It is important to provide lifestyle
modifications to the survivors and their caregivers to prevent this. Interventions are needed to
promote rehabilitation and maintenance of physical performance to help improve quality of
life and ongoing child development. Gotte, Taraks and Boos (9) found that physical activity
has a positive impact on acute side effects and late effects of childhood cancer and its
treatment. The effects of exercise as a co-treatment may be used as a noninvasive, nonpharmaceutical treatment to target physical limitations post treatment. Exercise interventions
are shown to improve cardiorespiratory fitness, improve muscle strength, and increase muscle
mass in children following SCT. The optimal distribution of type, intensity, duration, and
frequency of physical activity across a childhood cancer survivor’s lifespan remains unclear.
Age, gender, and site specific guidelines supports moderate physical activity levels based
upon the American College Sport Medicine’s (1) exercise prescription guidelines of cancer
patients and general population.
The inclusion of all studies that met criteria was necessary for this review; there is a possibility
that some studies may have been missed on account of human error. The comprehensive
search revealed only publications in the English language and may have excluded necessary
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research. Only one reviewer performed the search and rated the quality of the evidence, which
could have led to selection bias. A number of studies were excluded from the review because
they did not exclusively meet selection criteria. Studies that were included in the review
utilized small sample sizes that considered different types of cancer and treatment. The
included studies used different test measures for each of the variables, with the exception of
Hovi et al. (14) and Taskinen et al. (26). Some studies were the first to analyze global physical
functioning in childhood cancer patients that used testing batteries that were typically
developed for healthy populations.
Although the avoidance of late effects on motor performance cannot be guaranteed, the impact
on participation in daily activities and physical activity can be influenced by rehabilitation
strategies. The strategies are designed to restore function or prevent loss in physical
performance during the treatment process. Adult survivors of childhood cancer should be
monitored for functional loss throughout their lives. This is due to higher risk of performance
limitations and participation restrictions they may face many years after treatment. A global
test battery should be developed to test motor performance in hospital environments.
Designing specific rehabilitation programs would guide further comprehensive research on
the subject. Understanding which motor skills are affected by treatment allows practitioners
and rehabilitation specialists to design specific programs for individuals affected by cancer
treatment. This could prevent performance limitations and help improve long term effects of
treatment on motor performance. Additional clinical trials regarding performance limitations
are needed to examine short term and long term effects of cancer and treatment. Future studies
should examine the effects of an exercise intervention on motor performance in large cohorts
of pediatric cancer patients during and after treatment. This will enable researchers to identify
if exercise can be used as a preventative measure for deficiencies in motor performance.
Motor performance limitations caused by cancer and its treatment in childhood cancer
survivors within five years of treatment were reviewed. Strength and flexibility are the most
effected motor performance variables post cancer treatment showing declines in performance
when compared to healthy counterparts. This suggests that atrophy and stiffness initiated by
bed rest and physical inactivity may cause deficiencies in motor performance. Conflicting
research in balance, coordination, and reaction time needs further consideration. Patients with
a diagnosis of cancer are at risk of becoming survivors with lasting impairments across
multiple body systems. This needs to be addressed by rehabilitation professionals if these are
to be appropriately identified and prevented. Health care professionals treating pediatric
cancer survivors should manage physical morbidity caused by cancer and its treatment using
interventions that can minimize long term impact on motor abilities. Physical activity using
gross and fine motor movements should be performed by the patient as a preventative
measure for secondary disease.
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